Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 6 Bromonaphthalene 1,2 Diamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112679365A reveals a scalable 4-step synthesis for 6-bromonaphthalene-1,2-diamine, a key HCV inhibitor intermediate, offering cost-effective manufacturing solutions.